Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis - PubMed (original) (raw)
. 2004 Apr 15;428(6984):758-63.
doi: 10.1038/nature02444.
Masanori Inui, Kazuya Inoue, Sunhwa Kim, Ayako Suematsu, Eiji Kobayashi, Toshio Iwata, Hiroshi Ohnishi, Takashi Matozaki, Tatsuhiko Kodama, Tadatsugu Taniguchi, Hiroshi Takayanagi, Toshiyuki Takai
Affiliations
- PMID: 15085135
- DOI: 10.1038/nature02444
Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis
Takako Koga et al. Nature. 2004.
Abstract
Costimulatory signals are required for activation of immune cells, but it is not known whether they contribute to other biological systems. The development and homeostasis of the skeletal system depend on the balance between bone formation and resorption. Receptor activator of NF-kappaB ligand (RANKL) regulates the differentiation of bone-resorbing cells, osteoclasts, in the presence of macrophage-colony stimulating factor (M-CSF). But it remains unclear how RANKL activates the calcium signals that lead to induction of nuclear factor of activated T cells c1, a key transcription factor for osteoclastogenesis. Here we show that mice lacking immunoreceptor tyrosine-based activation motif (ITAM)-harbouring adaptors, Fc receptor common gamma subunit (FcRgamma) and DNAX-activating protein (DAP)12, exhibit severe osteopetrosis owing to impaired osteoclast differentiation. In osteoclast precursor cells, FcRgamma and DAP12 associate with multiple immunoreceptors and activate calcium signalling through phospholipase Cgamma. Thus, ITAM-dependent costimulatory signals activated by multiple immunoreceptors are essential for the maintenance of bone homeostasis. These results reveal that RANKL and M-CSF are not sufficient to activate the signals required for osteoclastogenesis.
Similar articles
- Regulation of ITAM adaptor molecules and their receptors by inhibition of calcineurin-NFAT signalling during late stage osteoclast differentiation.
Zawawi MS, Dharmapatni AA, Cantley MD, McHugh KP, Haynes DR, Crotti TN. Zawawi MS, et al. Biochem Biophys Res Commun. 2012 Oct 19;427(2):404-9. doi: 10.1016/j.bbrc.2012.09.077. Epub 2012 Sep 20. Biochem Biophys Res Commun. 2012. PMID: 23000414 - Mechanistic insight into osteoclast differentiation in osteoimmunology.
Takayanagi H. Takayanagi H. J Mol Med (Berl). 2005 Mar;83(3):170-9. doi: 10.1007/s00109-004-0612-6. Epub 2005 Jan 26. J Mol Med (Berl). 2005. PMID: 15776286 Review. - The antirheumatic drug leflunomide inhibits osteoclastogenesis by interfering with receptor activator of NF-kappa B ligand-stimulated induction of nuclear factor of activated T cells c1.
Urushibara M, Takayanagi H, Koga T, Kim S, Isobe M, Morishita Y, Nakagawa T, Löeffler M, Kodama T, Kurosawa H, Taniguchi T. Urushibara M, et al. Arthritis Rheum. 2004 Mar;50(3):794-804. doi: 10.1002/art.20206. Arthritis Rheum. 2004. PMID: 15022321 - Siglec-15 regulates osteoclast differentiation by modulating RANKL-induced phosphatidylinositol 3-kinase/Akt and Erk pathways in association with signaling Adaptor DAP12.
Kameda Y, Takahata M, Komatsu M, Mikuni S, Hatakeyama S, Shimizu T, Angata T, Kinjo M, Minami A, Iwasaki N. Kameda Y, et al. J Bone Miner Res. 2013 Dec;28(12):2463-75. doi: 10.1002/jbmr.1989. J Bone Miner Res. 2013. PMID: 23677868 - Osteoclast signalling pathways.
Blair HC, Robinson LJ, Zaidi M. Blair HC, et al. Biochem Biophys Res Commun. 2005 Mar 18;328(3):728-38. doi: 10.1016/j.bbrc.2004.11.077. Biochem Biophys Res Commun. 2005. PMID: 15694407 Review.
Cited by
- Osteoclast Signal Transduction During Bone Metastasis Formation.
Győri DS, Mócsai A. Győri DS, et al. Front Cell Dev Biol. 2020 Jun 19;8:507. doi: 10.3389/fcell.2020.00507. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 32637413 Free PMC article. Review. - Nuclear receptors in bone physiology and diseases.
Imai Y, Youn MY, Inoue K, Takada I, Kouzmenko A, Kato S. Imai Y, et al. Physiol Rev. 2013 Apr;93(2):481-523. doi: 10.1152/physrev.00008.2012. Physiol Rev. 2013. PMID: 23589826 Free PMC article. Review. - Homer2 and Homer3 modulate RANKL-induced NFATc1 signaling in osteoclastogenesis and bone metabolism.
Son A, Kang N, Oh SY, Kim KW, Muallem S, Yang YM, Shin DM. Son A, et al. J Endocrinol. 2019 Sep;242(3):241-249. doi: 10.1530/JOE-19-0123. J Endocrinol. 2019. PMID: 31319381 Free PMC article. - Negative feedback control of osteoclast formation through ubiquitin-mediated down-regulation of NFATc1.
Kim JH, Kim K, Jin HM, Song I, Youn BU, Lee SH, Choi Y, Kim N. Kim JH, et al. J Biol Chem. 2010 Feb 19;285(8):5224-31. doi: 10.1074/jbc.M109.042812. Epub 2009 Dec 26. J Biol Chem. 2010. PMID: 20037154 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials